A comprehensive view of Novartis AG. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

MorphoSys AG's subsidiary Constellation Pharmaceuticals partners with Novartis to research & commercialize pre-clinical of novel cancer target; MorphoSys receives US$23.0M payment, is eligible for milestone payments, royalties on net sales
Published: December 07, 2022 by dpa-AFX International Compact
INTERNATIONAL PATENT: NOVARTIS AG FILES APPLICATION FOR "USE OF 1,2,4-OXADIAZOLE DERIVATIVES AS LIVER X RECEPTOR AGONISTS"
Published: December 06, 2022 by U.S. Fed News
INTERNATIONAL PATENT: NOVARTIS AG FILES APPLICATION FOR "METHODS FOR THE TREATMENT OF OSTEOARTHRITIS"
Published: December 06, 2022 by U.S. Fed News
INTERNATIONAL PATENT: NOVARTIS AG FILES APPLICATION FOR "TRIAZOLO-PYRIMIDINE ANALOGUES FOR TREATING DISEASES CONNECTED TO THE INHIBITON OF WERNER SYNDROME RECQ HELICASE (WRN)"
Published: December 06, 2022 by U.S. Fed News
Novartis sells its Spanish headquarters in Barcelona, Spain, to the Freo Group as it reduces space for teleworking; Novartis to rent half of the 12,000 square-meter, nine floor building
Published: December 01, 2022 by CE Noticias Financieras (Latin America)

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count